INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 100 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $137,000 | -74.2% | 120,097 | -49.1% | 0.04% | -73.1% |
Q4 2021 | $531,000 | -34.3% | 236,160 | 0.0% | 0.13% | -37.4% |
Q3 2021 | $808,000 | -41.2% | 236,160 | -48.6% | 0.21% | -25.4% |
Q2 2021 | $1,373,000 | -7.4% | 459,260 | 0.0% | 0.29% | -18.5% |
Q1 2021 | $1,483,000 | – | 459,260 | – | 0.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |